Ruggeri, Zaverio M.; Ruf, Wolfram
Is VITT really a HITNATURE IMMUNOLOGY. Bd. 22. H. 11. 2021 S. 1352-1353
Leypoldt, Lisa B.; Besemer, Britta; Asemissen, Anne Marie et al.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trialLEUKEMIA. Bd. 36. H. 3. 2021 S. 885-888
Hamzic, Samra; Schramm, Patrick; Khilan, Hassan et al.
Isolated Dysphagia in a Patient with Medial Medullary Infarction - Effects of Evidence-Based Dysphagia Therapy: A Case ReportCASE REPORTS IN NEUROLOGY. Bd. 13. H. 1. 2021 S. 190-199
Gribko, Alena; Stiefel, Janis; Liebetanz, Lana et al.
IsoMAG-An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor CellsDIAGNOSTICS. Bd. 11. H. 11. 2021
Gribko, Alena; Stiefel, Janis; Liebetanz, Lana et al.
IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor CellsDiagnostics. Bd. 11. H. 11. MDPI AG 2021 S. 2040
Gutzmer, Ralf; Loquai, Carmen; Robert, Caroline et al.
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc AnalysisDERMATOLOGY AND THERAPY. Bd. 11. H. 5. 2021 S. 1839-1849
Ridder, Dirk Andreas; Schindeldecker, Mario; Weinmann, Arndt et al.
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular CarcinomaCANCERS. Bd. 13. H. 4. 2021
Malin, Jakob J.; Spinner, Christoph D.; Janssens, Uwe et al.
Key summary of German national treatment guidance for hospitalized COVID-19 patients (Jul, 10.1007/s15010-021-01645-2, 2021)INFECTION. Bd. 50. H. 1. 2021 S. 107-108
Malin, Jakob J.; Spinner, Christoph D.; Janssens, Uwe et al.
Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)INFECTION. Bd. 50. H. 1. 2021 S. 93-106
Shah, Manish A.; Bennouna, Jaafar; Doi, Toshihiko et al.
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinomaFUTURE ONCOLOGY. Bd. 17. H. 10. 2021 S. 1143-1153